Free Trial
TSE:HLS

HLS Therapeutics (HLS) Stock Price, News & Analysis

HLS Therapeutics logo
C$4.80 +0.01 (+0.21%)
As of 06/30/2025 03:59 PM Eastern

About HLS Therapeutics Stock (TSE:HLS)

Key Stats

Today's Range
C$4.80
C$4.85
50-Day Range
C$4.17
C$5.05
52-Week Range
C$3.00
C$5.23
Volume
47,701 shs
Average Volume
13,640 shs
Market Capitalization
C$106.79 million
P/E Ratio
N/A
Dividend Yield
4.17%
Price Target
C$4.50
Consensus Rating
Hold

Company Overview

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.

Receive HLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HLS Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

HLS Stock News Headlines

HLS Therapeutics Reports Annual Meeting Results
Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.
HLS Therapeutics Announces Q1 2025 Financial Results
HLS Therapeutics Inc (HLS) Receives a Hold from Stifel Nicolaus
See More Headlines

HLS Stock Analysis - Frequently Asked Questions

HLS Therapeutics' stock was trading at C$3.93 at the beginning of 2025. Since then, HLS stock has increased by 22.1% and is now trading at C$4.80.
View the best growth stocks for 2025 here
.

HLS Therapeutics Inc. (TSE:HLS) posted its quarterly earnings results on Thursday, November, 7th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by $0.01. HLS Therapeutics had a negative trailing twelve-month return on equity of 25.27% and a negative net margin of 38.70%.
Read the conference call transcript
.

Shares of HLS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that HLS Therapeutics investors own include Toronto-Dominion Bank (TD), Meta Platforms (META), NVIDIA (NVDA), CohBar (CWBR), Alphabet (GOOG), Great-West Lifeco (GWO) and ObsEva (OBSV).

Company Calendar

Last Earnings
11/07/2024
Today
7/01/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
TSE:HLS
CIK
N/A
Fax
N/A
Employees
91
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$4.50
High Stock Price Target
C$5.00
Low Stock Price Target
C$4.00
Potential Upside/Downside
-6.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$15.53 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$40.13 million
Cash Flow
C$0.32 per share
Price / Cash Flow
15.22
Book Value
C$2.51 per share
Price / Book
1.91

Miscellaneous

Free Float
N/A
Market Cap
C$106.79 million
Optionable
Not Optionable
Beta
1.07
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (TSE:HLS) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners